Legal Representation
Attorney
Brooke Erdos Singer
USPTO Deadlines
Next Deadline
2822 days remaining
Section 8 & 9 (20-Year) Renewal Due (Based on registration date 2013-04-23)
Due Date
April 23, 2033
Grace Period Ends
October 23, 2033
Application History
19 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Nov 29, 2019 | C8.. | O | CANCELLED SEC. 8 (6-YR) | Loading... |
| Apr 23, 2018 | REM1 | E | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | Loading... |
| Apr 23, 2013 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Feb 5, 2013 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Feb 5, 2013 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jan 16, 2013 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Dec 29, 2012 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Dec 27, 2012 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Dec 7, 2012 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Dec 6, 2012 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Dec 6, 2012 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Dec 6, 2012 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Dec 1, 2012 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Dec 1, 2012 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Dec 1, 2012 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Nov 30, 2012 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Aug 14, 2012 | MDSC | O | NOTICE OF DESIGN SEARCH CODE MAILED | Loading... |
| Aug 13, 2012 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Aug 7, 2012 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Additional Information
Design Mark
The mark consists of a stylized box showing three sides, with the top appearing in light orange, the left side appearing in dark orange and the right side appearing in gray.
Color Claim
The color(s) orange and gray is/are claimed as a feature of the mark.